Results 111 to 120 of about 7,253,207 (381)

Plasma lipidomic and metabolomic profiles in high‐grade glioma patients before and after 72‐h presurgery water‐only fasting

open access: yesMolecular Oncology, EarlyView.
Presurgery 72‐h fasting in GB patients leads to adaptations of plasma lipids and polar metabolites. Fasting reduces lysophosphatidylcholines and increases free fatty acids, shifts triglycerides toward long‐chain TGs and increases branched‐chain amino acids, alpha aminobutyric acid, and uric acid.
Iris Divé   +7 more
wiley   +1 more source

Spectrophotometric Determination of some Drugs using Oxidation Reduction Reactions

open access: yesIbn Al-Haitham Journal for Pure and Applied Sciences, 2019
     A spectrophotometric method is proposed for the determination of some drugs containing amino group such as mesalazine, metoclopramide and dopamine in pharmaceutical formulations.
Basima A. A. Saleem
doaj   +1 more source

Further Micro-Injection Studies on the Oxidation-Reduction Potential of the Cell-Interior

open access: yes, 1926
In previous communications on this subject (20, 21, 22) we described the results obtained when coloured indicators of known physico-chemical properties were injected into individual living cells.
J. Needham, D. Needham
semanticscholar   +1 more source

Ordered PdCu-Based Nanoparticles as Bifunctional Oxygen-Reduction and Ethanol-Oxidation Electrocatalysts.

open access: yesAngewandte Chemie, 2016
The development of superior non-platinum electrocatalysts for enhancing the electrocatalytic activity and stability for the oxygen-reduction reaction (ORR) and liquid fuel oxidation reaction is very important for the commercialization of fuel cells, but ...
K. Jiang   +7 more
semanticscholar   +1 more source

Targeting the MDM2‐MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
This study investigates an alternative approach to reactivating the oncosuppressor p53 in cancer. A short peptide targeting the association of the two p53 inhibitors, MDM2 and MDM4, induces an otherwise therapeutically active p53 with unique features that promote cell death and potentially reduce toxicity towards proliferating nontumor cells.
Sonia Valentini   +10 more
wiley   +1 more source

Studies in Oxidation-Reduction

open access: yesNature
THIS bulletin, obtainable for a mere half a dollar, consists of reprints of the masterly series researches published by W. Mansfield Clark and his associates from 1923 onwards. Twelve pages supplementary notes have been included.
W., Mansfield, Clark
semanticscholar   +1 more source

Elucidating prognostic significance of purine metabolism in colorectal cancer through integrating data from transcriptomic, immunohistochemical, and single‐cell RNA sequencing analysis

open access: yesMolecular Oncology, EarlyView.
Low expression of five purine metabolism‐related genes (ADSL, APRT, ADCY3, NME3, NME6) was correlated with poor survival in colorectal cancer. Immunohistochemistry analysis showed that low NME3 (early stage) and low ADSL/NME6 (late stage) levels were associated with high risk.
Sungyeon Kim   +8 more
wiley   +1 more source

Unraveling the thermodynamics and mechanism behind the lowering of reduction temperatures in oxide mixtures [PDF]

open access: yesarXiv
Hydrogen-based direct reduction offers a sustainable pathway to decarbonize the metal production industry. However, stable metal oxides, like Cr$_2$O$_3$, are notoriously difficult to reduce, requiring extremely high temperatures (above 1300 $^\circ$C).
arxiv  

Reduced Graphene Oxide and Its Natural Counterpart Shungite Carbon [PDF]

open access: yesarXiv, 2016
Large variety of structure and chemical-composition of reduced graphene oxide (RGO) is explained from a quantum-chemical standpoint. The related molecular theory of graphene oxide, supported by large experience gained by the modern graphene science, has led the foundation of the concept of a multi-stage graphene oxide reduction.
arxiv  

Home - About - Disclaimer - Privacy